In response to a severe degeneration of inhibitory Purkinje cells and focal necrotic lesions in the cerebellar cortex of patients with PMD, we next investigated whether c-Fos protein expression, a marker of neuronal hyperactivity [9], was increased. The gene discussed is FOS; the disease is Pelizeaus-Merzbacher spectrum disorder.